Northolt, United Kingdom

David B Ewan


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of David B. Ewan

Introduction

David B. Ewan is an accomplished inventor based in Northolt, GB. With a focus on pharmaceutical innovations, Ewan has developed significant formulations that may contribute to medical advancements. Notably, he holds a patent for a compound that could improve the treatment of dysrhythmias in both humans and animals.

Latest Patents

Ewan's sole patent is for 11.alpha.-Amino-3.beta.-hydroxy-androstanes. This patent involves compounds designed with the formula where R¹ is a C¹-8 alkyl group or a C³-7 cycloalkyl group, and R² is a C¹-6 alkyl group or a C³-6 cycloalkyl group, along with D-homo analogues possessing the group --CO₂R² at the 17.alpha.,β-position. These compounds exhibit potential as antidysthythmic agents and can be incorporated into pharmaceutical compositions for further applications. The invention also discusses intermediates useful for producing these compounds and various processes for their synthesis, highlighting Ewan's innovative approaches to steroid production.

Career Highlights

David B. Ewan is associated with Glaxo Group Limited, where his expertise in medicinal chemistry allows him to contribute significantly to the pharmaceutical field. His innovative work has implications for the treatment of heart conditions, showcasing his dedication to enhancing healthcare solutions through his inventions.

Collaborations

Throughout his career, Ewan has collaborated with notable colleagues, including Gordon H. Phillipps and David C. Humber. These partnerships have fostered a collaborative environment leading to advancements in medicinal products and reinforced the capabilities of their research team.

Conclusion

David B. Ewan continues to be a pivotal figure in pharmaceutical innovation, with his patent showcasing the potential benefits of his compounds in treating dysrhythmias. As he advances his research within Glaxo Group Limited, Ewan symbolizes the enduring impact that inventors can have on society through their groundbreaking work in medicine and health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…